Literature DB >> 30607613

Marked impact of tumor location on the appropriate cutoff values and the prognostic significance of the lymph node ratio in stage III colon cancer: a multi-institutional retrospective analysis.

Eiji Shinto1, Hideyuki Ike2, Jin-Ichi Hida3, Hirotoshi Kobayashi4, Yojiro Hashiguchi5, Yoshiki Kajiwara6, Kazuo Hase6, Hideki Ueno6, Kenichi Sugihara7.   

Abstract

BACKGROUND: The prognostic significance of lymph node ratio (LNR) is not constant among studies. Exploration of appropriate location-specific cutoffs might be necessary because the number of lymph nodes harvested is generally higher in right than in left colon cancer. We aimed to determine appropriate cutoff values of LNR in right and left colon cancer and to clarify its clinical significance.
METHODS: The clinicopathologic data of 5463 patients with stage III colon cancer were collected. The best cutoff for LNR as a prognostic indicator for patients with right and left colon cancer was studied separately. We compared the prognostic impact between LNR and the number of lymph node metastasis using the Akaike information criterion (AIC), and evaluated the prognostic significance of LNR in each stage III subcategory.
RESULTS: The best performance was noted when LNR was categorized by cutoffs of 0.16 and 0.22 for right and left colon cancer, respectively. AIC scores were better with these categorizations than with subgrouping by number of positive nodes. LNR-low right colon cancer patients showed better cancer-specific survival than LNR-high in stage IIIA (95.7% vs. 89.3%), IIIB (86.7% vs. 77.2%), and IIIC (71.2% vs. 58.7%). The same results were obtained in left colon cancer patients with stage IIIB (88.3% vs. 80.7%) and IIIC (79.8% vs. 68.4%).
CONCLUSIONS: We demonstrated the difference in the appropriate cutoffs of LNR between right and left colon cancer. Categorization by location-specific cutoff of LNR may be useful for risk stratification of patients with stage III cancer.

Entities:  

Keywords:  Lymph node ratio; Sidedness; Stage III colon cancer; The number of lymph nodes

Mesh:

Year:  2019        PMID: 30607613     DOI: 10.1007/s00535-018-01539-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

1.  Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer.

Authors:  Hirotoshi Kobayashi; Hideki Ueno; Yojiro Hashiguchi; Hidetaka Mochizuki
Journal:  Surgery       Date:  2006-04       Impact factor: 3.982

2.  Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

Authors:  Samuel J Wang; Andrew Lemieux; Jayashree Kalpathy-Cramer; Celine B Ord; Gary V Walker; C David Fuller; Jong-Sung Kim; Charles R Thomas
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

3.  Number versus distribution in classifying regional lymph node metastases from colon cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Masayuki Yasutomi; Takehito Yoshifuji; Tomohiko Matsuzaki; Toshihiro Uchida; Eizaburou Ishimaru; Tadao Tokoro; Hitoshi Shiozaki
Journal:  J Am Coll Surg       Date:  2005-08       Impact factor: 6.113

4.  Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.

Authors:  Carlos A Vaccaro; Victor Im; Gustavo L Rossi; Guillermo Ojea Quintana; Mario L Benati; Diego Perez de Arenaza; Fernando A Bonadeo
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

5.  Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

Authors:  Adam C Berger; Elin R Sigurdson; Thomas LeVoyer; Alexandra Hanlon; Robert J Mayer; John S Macdonald; Paul J Catalano; Daniel G Haller
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

6.  Evaluation of the seventh edition of the tumour, node, metastasis (TNM) classification for colon cancer in two nationwide registries of the United States and Japan.

Authors:  Y Hashiguchi; K Hase; K Kotake; H Ueno; E Shinto; H Mochizuki; J Yamamoto; K Sugihara
Journal:  Colorectal Dis       Date:  2012-09       Impact factor: 3.788

7.  Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

Authors:  Robert Rosenberg; Jan Friederichs; Tibor Schuster; Ralf Gertler; Matthias Maak; Karen Becker; Anne Grebner; Kurt Ulm; Heinz Höfler; Hjalmar Nekarda; Jörg-Rüdiger Siewert
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

8.  Is there a difference in survival between right- versus left-sided colon cancers?

Authors:  Robert A Meguid; Mark B Slidell; Christopher L Wolfgang; David C Chang; Nita Ahuja
Journal:  Ann Surg Oncol       Date:  2008-07-12       Impact factor: 5.344

9.  The metastatic lymph node ratio predicts survival in colon cancer.

Authors:  Paul Schumacher; Sean Dineen; Carlton Barnett; Jason Fleming; Thomas Anthony
Journal:  Am J Surg       Date:  2007-12       Impact factor: 2.565

10.  Impact of tumor location on nodal evaluation for colon cancer.

Authors:  Karl Y Bilimoria; Bryan Palis; Andrew K Stewart; David J Bentrem; Andrew C Freel; Elin R Sigurdson; Mark S Talamonti; Clifford Y Ko
Journal:  Dis Colon Rectum       Date:  2008-01-03       Impact factor: 4.585

View more
  4 in total

Review 1.  Beyond N staging in colorectal cancer: Current approaches and future perspectives.

Authors:  Gianluca Arrichiello; Mario Pirozzi; Bianca Arianna Facchini; Sergio Facchini; Fernando Paragliola; Valeria Nacca; Antonella Nicastro; Maria Anna Canciello; Adele Orlando; Marianna Caterino; Davide Ciardiello; Carminia Maria Della Corte; Morena Fasano; Stefania Napolitano; Teresa Troiani; Fortunato Ciardiello; Giulia Martini; Erika Martinelli
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

2.  Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis.

Authors:  Xiangyi Pang; Benjie Xu; Jie Lian; Ren Wang; Xin Wang; Jiayue Shao; Shuli Tang; Haibo Lu
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

3.  Accurate Prediction of Prognosis by Integrating Clinical and Molecular Characteristics in Colon Cancer.

Authors:  Liru Wang; Mu Su; Mengyan Zhang; Hongyan Zhao; Hongli Wang; Jie Xing; Chenyu Guo; Dianshuang Zhou; Wenhui Xue; Haibo Lu; Yan Zhang
Journal:  Front Cell Dev Biol       Date:  2021-05-21

4.  Number of negative lymph nodes with a positive impact on survival of stage III colon cancer; a retrospective observation study for right side and left side colon.

Authors:  Yi-Hung Kuo; Jeng-Fu You; Hsin-Yuan Hung; Chih-Chien Chin; Jy-Ming Chiang; Chia-Hao Chang
Journal:  BMC Cancer       Date:  2022-01-31       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.